{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T15:40:04Z","timestamp":1744040404375,"version":"3.40.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1007\/s11864-000-0012-2","type":"journal-article","created":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T08:52:11Z","timestamp":1185439931000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acute lymphoblastic leukemia in adults"],"prefix":"10.1007","volume":"1","author":[{"given":"Mark R.","family":"Litzow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJM199506153322407","volume":"332","author":"C-H Pui","year":"1995","unstructured":"Pui C-H: Childhood leukemias. N Engl J Med 1995, 332:1618\u20131630.","journal-title":"N Engl J Med"},{"key":"12_CR2","unstructured":"Stock W: Treatment of adult lymphoblastic leukemia: risk-adapted strategies.\n                           Hematology 1999: 87\u201396. An excellent and succinct current review of the therapy of adult ALL."},{"key":"12_CR3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","volume":"85","author":"RA Larson","year":"1995","unstructured":"Larson RA, Dodge RK, Burns CP, et al.: A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 1995, 85:2025\u20132037. A large trial demonstrating the effectiveness of multi-agent chemotherapy optimally applied in the cooperative group setting. Outlines outcome of therapy related to established risk factors.","journal-title":"Blood"},{"key":"12_CR4","first-page":"3983","volume":"93","author":"M Wetzler","year":"1999","unstructured":"Wetzler M, Dodge RK, Mrozek K, et al.: Prospective karyotype analysis in acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience. Blood 1999, 93:3983\u20133993.","journal-title":"Blood"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D, Ludwig W-D, Thiel E, et al.: Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996, 87:495\u2013508.","journal-title":"Blood"},{"key":"12_CR6","unstructured":"Forman SJ: Transplant approaches to high-risk ALL.\n                           Hematology 1999:96\u2013101."},{"key":"12_CR7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7326\/0003-4819-123-6-199509150-00006","volume":"123","author":"M-J Zhang","year":"1995","unstructured":"Zhang M-J, Hoelzer D, Horowitz MM, et al.: Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. Ann Intern Med 1995, 123:428\u2013431.","journal-title":"Ann Intern Med"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.1994.12.12.2580","volume":"12","author":"C Sebban","year":"1994","unstructured":"Sebban C, Lepage E, Vernant J-P, et al.: Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. J Clin Oncol 1994, 12:2580\u20132587.","journal-title":"J Clin Oncol"},{"key":"12_CR9","first-page":"221","volume-title":"Acute Lymphoblastic Leukemia","author":"D Hoelzer","year":"1990","unstructured":"Hoelzer D, Thiel E, L\u00f6ffler H, et al.: Intensified chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia. In Acute Lymphoblastic Leukemia. Edited by Gale RP, Hoelzer D. New York, NY: Liss; 1990:221\u2013229."},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1056\/NEJM198708203170801","volume":"317","author":"JH Kersey","year":"1987","unstructured":"Kersey JH, Weisdorf D, Nesbit ME, et al.: Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987, 317:461\u2013467.","journal-title":"N Engl J Med"},{"key":"12_CR11","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V86.4.1619.bloodjournal8641619","volume":"86","author":"M Attal","year":"1995","unstructured":"Attal M, Blaise D, Marit G, et al.: Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. Blood 1995, 86:1619\u20131628.","journal-title":"Blood"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V90.8.2962","volume":"90","author":"DJ Weisdorf","year":"1997","unstructured":"Weisdorf DJ, Billett AL, Hannan P, et al.: Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood 1997, 90:2962\u20132968. Retrospectively addresses the difficult question of whether to consider autologous or unrelated donor allogeneic transplant for patients lacking an HLA-matched sibling donor.","journal-title":"Blood"},{"key":"12_CR13","first-page":"669a","volume":"88","author":"J Kurtzberg","year":"1996","unstructured":"Kurtzberg J, Keating M, Moore JO, et al.: 2-amino-9-B-D-Arabinosyl-6-methoxy-9H-Guanine (GW506U; Compound 506U) is highly active in patients with T-cell malignancies: results of a phase I trial in pediatric and adult patients with refractory hematologic malignancies. Blood 1996, 88:669a.","journal-title":"Blood"},{"key":"12_CR14","first-page":"238a","volume":"90","author":"JC Byrd","year":"1997","unstructured":"Byrd JC, Waselenko JK, Shinn CA, et al.: FR90128, a novel antitumor bicyclic depsipeptide has marked in vitro activity against both the K-562 cell line and human acute leukemia cells. Blood 1997, 90:238a.","journal-title":"Blood"},{"key":"12_CR15","first-page":"246a","volume":"90","author":"CA Shinn","year":"1997","unstructured":"Shinn CA, Byrd JC, Waselenko JK, et al.: UCN-01 has significant in vitro activity in both the resistant K-562 cell line and human acute leukemia cells. Blood 1997, 90:246a.","journal-title":"Blood"},{"key":"12_CR16","first-page":"248a","volume":"90","author":"JK Waselenko","year":"1997","unstructured":"Waselenko JK, Byrd JC, Shinn CA, et al.: Flavopiridol has marked in vitro activity against both the K-562 cell line and human acute leukemia cells. Blood 1997, 90:248a.","journal-title":"Blood"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1046\/j.1365-2141.1998.00869.x","volume":"102","author":"Y Akao","year":"1998","unstructured":"Akao Y, Mizoguchi H, Kojima S, et al.: Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein. Br J Haematol 1998, 102:1055\u20131060.","journal-title":"Br J Haematol"},{"key":"12_CR18","first-page":"301a","volume":"84","author":"JE Kolitz","year":"1994","unstructured":"Kolitz JE, O\u2019Mara V, Willemze R, et al.: Treatment of acute lymphoblastic leukemia with campath-1H: initial observations. Blood 1994, 84:301a.","journal-title":"Blood"},{"issue":"suppl 1","key":"12_CR19","first-page":"295a","volume":"94","author":"Y Messinger","year":"1999","unstructured":"Messinger Y, Chen C-L, O\u2019Neill K, et al.: Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor. Blood 1999, 94(suppl 1):295a.","journal-title":"Blood"},{"issue":"suppl 1","key":"12_CR20","first-page":"697a","volume":"94","author":"BJ Druker","year":"1999","unstructured":"Druker BJ, Kantarjian H, Sawyers CL, et al.: Activity of an ABL specific tyrosine kinase inhibitor in patients with bcr-abl positive acute leukemias, including chronic myelogenous leukemia in blast crisis. Blood 1999 94 (suppl 1):697a.","journal-title":"Blood"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-000-0012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-000-0012-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-000-0012-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-000-0012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T15:03:33Z","timestamp":1744038213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-000-0012-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s11864-000-0012-2","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"type":"print","value":"1527-2729"},{"type":"electronic","value":"1534-6277"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}